Flexibility Required: Balancing the Interests of Children and Risk in Drug Development for Rare Pediatric Conditions.

There exists a standard approach to developing drugs for adults. The process begins with animal studies focused on toxicity, followed by phase I safety and dosage studies in humans, phase II effica...